PROFUSA, INC. Liabilities, Fair Value Adjustment
PROFUSA, INC. (PFSA) reported Liabilities, Fair Value Adjustment of $1.43 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-17.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:LiabilitiesFairValueAdjustment · last filed 2023-05-17
- PROFUSA, INC. liabilities, fair value adjustment for the quarter ending 2023-03-31 was $1.43M, a 57.10% decline year-over-year.
- PROFUSA, INC. liabilities, fair value adjustment for the quarter ending 2022-12-31 was -$111.34K.
- PROFUSA, INC. liabilities, fair value adjustment for the quarter ending 2022-09-30 was -$1.07M.
- PROFUSA, INC. liabilities, fair value adjustment for the quarter ending 2022-06-30 was -$1.29M.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 8 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|---|
| 2023-03-31 | $1.43M 10-Q · filed 2023-05-17 | $1.32M derived: sum of 2 quarters · filed 2023-05-17 | $246.21K derived: sum of 3 quarters · filed 2023-05-17 | -$1.05M derived: sum of 4 quarters · filed 2023-05-17 | |
| 2022-12-31 | -$111.34K derived: 10-Q 12 month − 10-Q 9 month · filed 2023-05-17 | -$1.19M derived: sum of 2 quarters · filed 2023-05-17 | -$2.48M derived: sum of 3 quarters · filed 2023-05-17 | $857.79K 10-Q · filed 2023-05-17 | |
| 2022-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.37M derived: sum of 2 quarters · filed 2022-11-10 | $969.13K 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.04M 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $3.34M 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | $7.22M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |